Sun, H., Werner, C., Dresser, J., Wilder-Romans, K., Baskin-Bey, E., Eisner, J., … Wahl, D. (2018). TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA (GBM) USING SEVITERONEL (SEVI), A CYP17 LYASE AND ANDROGEN RECEPTOR (AR) INHIBITOR, ALONE AND IN COMBINATION WITH RADIATION (RT). In NEURO-ONCOLOGY (Vol. 20, pp. 88–88).

Sun, Hanshi, Christian Werner, Joseph Dresser, Kari Wilder-Romans, Edwina Baskin-Bey, Joel Eisner, Theodore Lawrence, Daniel Spratt, Corey Speers, and Daniel Wahl. “TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA (GBM) USING SEVITERONEL (SEVI), A CYP17 LYASE AND ANDROGEN RECEPTOR (AR) INHIBITOR, ALONE AND IN COMBINATION WITH RADIATION (RT).” In NEURO-ONCOLOGY, 20:88–88, 2018.

Sun H, Werner C, Dresser J, Wilder-Romans K, Baskin-Bey E, Eisner J, et al. TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA (GBM) USING SEVITERONEL (SEVI), A CYP17 LYASE AND ANDROGEN RECEPTOR (AR) INHIBITOR, ALONE AND IN COMBINATION WITH RADIATION (RT). In: NEURO-ONCOLOGY. 2018. p. 88–88.

Sun, Hanshi, et al. “TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA (GBM) USING SEVITERONEL (SEVI), A CYP17 LYASE AND ANDROGEN RECEPTOR (AR) INHIBITOR, ALONE AND IN COMBINATION WITH RADIATION (RT).” NEURO-ONCOLOGY, vol. 20, 2018, pp. 88–88.

Sun H, Werner C, Dresser J, Wilder-Romans K, Baskin-Bey E, Eisner J, Lawrence T, Spratt D, Speers C, Wahl D. TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA (GBM) USING SEVITERONEL (SEVI), A CYP17 LYASE AND ANDROGEN RECEPTOR (AR) INHIBITOR, ALONE AND IN COMBINATION WITH RADIATION (RT). NEURO-ONCOLOGY. 2018. p. 88–88.